0001179110-13-011400.txt : 20130703
0001179110-13-011400.hdr.sgml : 20130703
20130703085126
ACCESSION NUMBER: 0001179110-13-011400
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20130701
FILED AS OF DATE: 20130703
DATE AS OF CHANGE: 20130703
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Celldex Therapeutics, Inc.
CENTRAL INDEX KEY: 0000744218
STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835]
IRS NUMBER: 133191702
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 119 FOURTH AVE
CITY: NEEDHAM
STATE: MA
ZIP: 02494
BUSINESS PHONE: 7814330771
MAIL ADDRESS:
STREET 1: 119 FOURTH AVE
CITY: NEEDHAM
STATE: MA
ZIP: 02494-2725
FORMER COMPANY:
FORMER CONFORMED NAME: AVANT IMMUNOTHERAPEUTICS INC
DATE OF NAME CHANGE: 19980828
FORMER COMPANY:
FORMER CONFORMED NAME: T CELL SCIENCES INC
DATE OF NAME CHANGE: 19920703
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Davis Thomas Andrew
CENTRAL INDEX KEY: 0001338185
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-15006
FILM NUMBER: 13951031
MAIL ADDRESS:
STREET 1: 65 WEST WATKINS MILL ROAD
CITY: GAITHERSBURG
STATE: MD
ZIP: 20878
4
1
edgar.xml
FORM 4 -
X0306
4
2013-07-01
0
0000744218
Celldex Therapeutics, Inc.
CLDX
0001338185
Davis Thomas Andrew
C/O CELLDEX THERAPEUTICS, INC.
119 FOURTH AVENUE
NEEDHAM
MA
02494
0
1
0
0
Sr. VP & CMO
Incentive Stock Option
16.36
2013-07-01
4
A
0
115000
0
A
2014-07-01
2023-07-01
Common Stock
115000
115000
D
25% vest on July 1, 2014 and the remainder vest quarterly (in equal amounts) over the subsequent 12 quarters.
/s/ Avery W. Catlin, attorney in fact for Thomas A. Davis
2013-07-03